Eton Pharmaceuticals Inc banner

Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 26.395 USD 5.33% Market Closed
Market Cap: $707.9m

Wall Street
Price Targets

ETON Price Targets Summary
Eton Pharmaceuticals Inc

Wall Street analysts forecast ETON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ETON is 38.42 USD with a low forecast of 30.3 USD and a high forecast of 54.6 USD.

Lowest
Price Target
30.3 USD
15% Upside
Average
Price Target
38.42 USD
46% Upside
Highest
Price Target
54.6 USD
107% Upside
Eton Pharmaceuticals Inc Competitors:
Price Targets
FCNCA
First Citizens BancShares Inc (Delaware)
20% Upside
SNNP
Srinanaporn Marketing PCL
15% Upside
AMBR
Amber International Holding Ltd
338% Upside

Revenue
Forecast

N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 41%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ETON's stock price target?
Price Target
38.42 USD

According to Wall Street analysts, the average 1-year price target for ETON is 38.42 USD with a low forecast of 30.3 USD and a high forecast of 54.6 USD.

What is Eton Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
41%

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 3 years is 41%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett